Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era

Nadine Norton, Peggy D. Robertson, Mark J. Rieder, Stephan Züchner, Evadnie Rampersaud, Eden Martin, Duanxiang Li, Deborah A. Nickerson, Ray E. Hershberger

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Background-Human exome sequencing is a recently developed tool to aid in the discovery of novel coding variants. Now broadly applied, exome sequencing data sets provide a novel opportunity to evaluate the allele frequencies of previously published pathogenic rare variants. Methods and Results-We examined the exome data set from the National Heart, Lung and Blood Institute Exome Sequencing Project and compared this data set with a catalog of 197 previously published rare variants reported as causative of dilated cardiomyopathy (DCM) from familial and sporadic cases. Of these 197, 33 (16.8%) were also present in the Exome Sequencing Project database, raising the question of whether they were uncommon polymorphisms. Supporting functional data has been published for 14 of the 33 (42%), suggesting they are unlikely to be false-positives. The frequencies of these functional variants in the Exome Sequencing Project data set ranged from 0.02 to 1.33% (median 0.04%), which when applied as a cutoff to filter variants in a DCM pedigree identified an additional DCM candidate gene. A greater proportion of sporadic DCM cases had variants that were present in the Exome Sequencing Project data set versus novel variants (ie, not in the Exome Sequencing Project; 44% versus 21%; P=0.002), suggesting some of the variants identified as disease causing in sporadic DCM are either false-positives or low penetrance alleles in human populations. Conclusions-Rare nonsynonymous variants identified in DCM subjects also present at very low frequencies in public databases are likely relevant for DCM. Allele frequencies >0.04% are of less certain pathogenicity, especially if identified in sporadic cases, although this cutoff should be viewed as preliminary.

Original languageEnglish (US)
Pages (from-to)167-174
Number of pages8
JournalCirculation: Cardiovascular Genetics
Volume5
Issue number2
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Exome
Dilated Cardiomyopathy
Virulence
Gene Frequency
Databases
National Heart, Lung, and Blood Institute (U.S.)
Penetrance
Pedigree
Alleles
Datasets

Keywords

  • Cardiomyopathy
  • Genes
  • Genetics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)
  • Genetics

Cite this

Norton, N., Robertson, P. D., Rieder, M. J., Züchner, S., Rampersaud, E., Martin, E., ... Hershberger, R. E. (2012). Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. Circulation: Cardiovascular Genetics, 5(2), 167-174. https://doi.org/10.1161/CIRCGENETICS.111.961805

Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. / Norton, Nadine; Robertson, Peggy D.; Rieder, Mark J.; Züchner, Stephan; Rampersaud, Evadnie; Martin, Eden; Li, Duanxiang; Nickerson, Deborah A.; Hershberger, Ray E.

In: Circulation: Cardiovascular Genetics, Vol. 5, No. 2, 04.2012, p. 167-174.

Research output: Contribution to journalArticle

Norton, N, Robertson, PD, Rieder, MJ, Züchner, S, Rampersaud, E, Martin, E, Li, D, Nickerson, DA & Hershberger, RE 2012, 'Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era', Circulation: Cardiovascular Genetics, vol. 5, no. 2, pp. 167-174. https://doi.org/10.1161/CIRCGENETICS.111.961805
Norton, Nadine ; Robertson, Peggy D. ; Rieder, Mark J. ; Züchner, Stephan ; Rampersaud, Evadnie ; Martin, Eden ; Li, Duanxiang ; Nickerson, Deborah A. ; Hershberger, Ray E. / Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. In: Circulation: Cardiovascular Genetics. 2012 ; Vol. 5, No. 2. pp. 167-174.
@article{63a56038a1484502ba1711e10254e2cc,
title = "Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era",
abstract = "Background-Human exome sequencing is a recently developed tool to aid in the discovery of novel coding variants. Now broadly applied, exome sequencing data sets provide a novel opportunity to evaluate the allele frequencies of previously published pathogenic rare variants. Methods and Results-We examined the exome data set from the National Heart, Lung and Blood Institute Exome Sequencing Project and compared this data set with a catalog of 197 previously published rare variants reported as causative of dilated cardiomyopathy (DCM) from familial and sporadic cases. Of these 197, 33 (16.8{\%}) were also present in the Exome Sequencing Project database, raising the question of whether they were uncommon polymorphisms. Supporting functional data has been published for 14 of the 33 (42{\%}), suggesting they are unlikely to be false-positives. The frequencies of these functional variants in the Exome Sequencing Project data set ranged from 0.02 to 1.33{\%} (median 0.04{\%}), which when applied as a cutoff to filter variants in a DCM pedigree identified an additional DCM candidate gene. A greater proportion of sporadic DCM cases had variants that were present in the Exome Sequencing Project data set versus novel variants (ie, not in the Exome Sequencing Project; 44{\%} versus 21{\%}; P=0.002), suggesting some of the variants identified as disease causing in sporadic DCM are either false-positives or low penetrance alleles in human populations. Conclusions-Rare nonsynonymous variants identified in DCM subjects also present at very low frequencies in public databases are likely relevant for DCM. Allele frequencies >0.04{\%} are of less certain pathogenicity, especially if identified in sporadic cases, although this cutoff should be viewed as preliminary.",
keywords = "Cardiomyopathy, Genes, Genetics",
author = "Nadine Norton and Robertson, {Peggy D.} and Rieder, {Mark J.} and Stephan Z{\"u}chner and Evadnie Rampersaud and Eden Martin and Duanxiang Li and Nickerson, {Deborah A.} and Hershberger, {Ray E.}",
year = "2012",
month = "4",
doi = "10.1161/CIRCGENETICS.111.961805",
language = "English (US)",
volume = "5",
pages = "167--174",
journal = "Circulation. Genomic and precision medicine",
issn = "1942-325X",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "2",

}

TY - JOUR

T1 - Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era

AU - Norton, Nadine

AU - Robertson, Peggy D.

AU - Rieder, Mark J.

AU - Züchner, Stephan

AU - Rampersaud, Evadnie

AU - Martin, Eden

AU - Li, Duanxiang

AU - Nickerson, Deborah A.

AU - Hershberger, Ray E.

PY - 2012/4

Y1 - 2012/4

N2 - Background-Human exome sequencing is a recently developed tool to aid in the discovery of novel coding variants. Now broadly applied, exome sequencing data sets provide a novel opportunity to evaluate the allele frequencies of previously published pathogenic rare variants. Methods and Results-We examined the exome data set from the National Heart, Lung and Blood Institute Exome Sequencing Project and compared this data set with a catalog of 197 previously published rare variants reported as causative of dilated cardiomyopathy (DCM) from familial and sporadic cases. Of these 197, 33 (16.8%) were also present in the Exome Sequencing Project database, raising the question of whether they were uncommon polymorphisms. Supporting functional data has been published for 14 of the 33 (42%), suggesting they are unlikely to be false-positives. The frequencies of these functional variants in the Exome Sequencing Project data set ranged from 0.02 to 1.33% (median 0.04%), which when applied as a cutoff to filter variants in a DCM pedigree identified an additional DCM candidate gene. A greater proportion of sporadic DCM cases had variants that were present in the Exome Sequencing Project data set versus novel variants (ie, not in the Exome Sequencing Project; 44% versus 21%; P=0.002), suggesting some of the variants identified as disease causing in sporadic DCM are either false-positives or low penetrance alleles in human populations. Conclusions-Rare nonsynonymous variants identified in DCM subjects also present at very low frequencies in public databases are likely relevant for DCM. Allele frequencies >0.04% are of less certain pathogenicity, especially if identified in sporadic cases, although this cutoff should be viewed as preliminary.

AB - Background-Human exome sequencing is a recently developed tool to aid in the discovery of novel coding variants. Now broadly applied, exome sequencing data sets provide a novel opportunity to evaluate the allele frequencies of previously published pathogenic rare variants. Methods and Results-We examined the exome data set from the National Heart, Lung and Blood Institute Exome Sequencing Project and compared this data set with a catalog of 197 previously published rare variants reported as causative of dilated cardiomyopathy (DCM) from familial and sporadic cases. Of these 197, 33 (16.8%) were also present in the Exome Sequencing Project database, raising the question of whether they were uncommon polymorphisms. Supporting functional data has been published for 14 of the 33 (42%), suggesting they are unlikely to be false-positives. The frequencies of these functional variants in the Exome Sequencing Project data set ranged from 0.02 to 1.33% (median 0.04%), which when applied as a cutoff to filter variants in a DCM pedigree identified an additional DCM candidate gene. A greater proportion of sporadic DCM cases had variants that were present in the Exome Sequencing Project data set versus novel variants (ie, not in the Exome Sequencing Project; 44% versus 21%; P=0.002), suggesting some of the variants identified as disease causing in sporadic DCM are either false-positives or low penetrance alleles in human populations. Conclusions-Rare nonsynonymous variants identified in DCM subjects also present at very low frequencies in public databases are likely relevant for DCM. Allele frequencies >0.04% are of less certain pathogenicity, especially if identified in sporadic cases, although this cutoff should be viewed as preliminary.

KW - Cardiomyopathy

KW - Genes

KW - Genetics

UR - http://www.scopus.com/inward/record.url?scp=84860826709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860826709&partnerID=8YFLogxK

U2 - 10.1161/CIRCGENETICS.111.961805

DO - 10.1161/CIRCGENETICS.111.961805

M3 - Article

C2 - 22337857

AN - SCOPUS:84860826709

VL - 5

SP - 167

EP - 174

JO - Circulation. Genomic and precision medicine

JF - Circulation. Genomic and precision medicine

SN - 1942-325X

IS - 2

ER -